A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.
Aleksandrova K, Chuang SC, Boeing H, Zuo H, Tell GS, Pischon T, Jenab M, Bueno-de-Mesquita B, Vollset SE, Midttun Ø, Ueland PM, Fedirko V, Johansson M, Weiderpass E, Severi G, Racine A, Boutron-Ruault MC, Kaaks R, Kühn T, Tjønneland A, Overvad K, Quirós JR, Jakszyn P, Sánchez MJ, Dorronsoro M, Chirlaque MD, Ardanaz E, Khaw KT, Wareham NJ, Travis RC, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Tumino R, Panico S, May AM, Palmqvist R, Ljuslinder I, Kong SY, Freisling H, Gunter MJ, Lu Y, Cross AJ, Riboli E, and Vineis P
Journal of the National Cancer Institute. Feb 2015
(DOI : 10.1093/jnci/djv010)